Index of reports
> Life Threatening Events (13)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Hydrocortisone (Hydrocortisone Topical) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Hydrocortisone side effects in female
Reported by a physician from Germany on 2012-08-10
Patient: female
Reactions: Cellulitis, C-Reactive Protein Increased, Necrosis, Lymphangitis, Aplastic Anaemia, Skin Necrosis, Empyema, Thermal Burn, White Blood Cell Count Increased
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Methotrexate
Administration route: Oral
Start date: 2007-06-19
Hydrocortisone
Indication: Rheumatoid Arthritis
Humira
Indication: Rheumatoid Arthritis
Start date: 2005-12-01
End date: 2006-12-01
Methotrexate
Indication: Rheumatoid Arthritis
Start date: 2005-12-01
End date: 2006-12-01
Other drugs received by patient: Prednisolone; Etanercept
Possible Hydrocortisone side effects in 14 year old female
Reported by a consumer/non-health professional from United States on 2012-05-24
Patient: 14 year old female, weighing 64.8 kg (142.6 pounds)
Reactions: Depressed Level of Consciousness, Encephalitic Infection, Cerebrovascular Accident, Hypertriglyceridaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-11
End date: 2012-03-02
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-11
End date: 2012-02-18
Pegaspargase
Dosage: 2500 iu, unk
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-11
End date: 2012-03-02
Hydrocortisone
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-11
Cytarabine
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
End date: 2012-02-06
Doxorubicin HCL
Dosage: 60 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-11
End date: 2012-02-11
Prednisone
Dosage: 20 mg/m2, cyclic
Administration route: Oral
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-11
End date: 2012-03-09
Methotrexate
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-11
Possible Hydrocortisone side effects in 80 year old female
Reported by a physician from Switzerland on 2012-05-14
Patient: 80 year old female
Reactions: Pulmonary Embolism
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Lucentis
End date: 2011-10-20
Lucentis
Lucentis
Indication: AGE-Related Macular Degeneration
Start date: 2008-12-08
Hydrocortisone
Administration route: Oral
Indication: Temporal Arteritis
Lucentis
Lucentis
Lucentis
Possible Hydrocortisone side effects in 14 year old female
Reported by a consumer/non-health professional from United States on 2012-05-11
Patient: 14 year old female, weighing 64.8 kg (142.6 pounds)
Reactions: Depressed Level of Consciousness, Encephalitic Infection, Cerebrovascular Accident, Hypertriglyceridaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
End date: 2012-02-06
Hydrocortisone
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-11
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-11
End date: 2012-02-18
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-11
End date: 2012-03-02
Prednisone TAB
Dosage: 20 mg/m2, cyclic
Administration route: Oral
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-11
End date: 2012-03-09
Pegaspargase
Dosage: 2500 iu, unk
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-11
End date: 2012-03-02
Doxorubicin HCL
Dosage: 60 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-11
End date: 2012-02-11
Methotrexate
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-11
Possible Hydrocortisone side effects in 13 year old female
Reported by a consumer/non-health professional from United States on 2012-03-29
Patient: 13 year old female, weighing 64.8 kg (142.6 pounds)
Reactions: Depressed Level of Consciousness, Hypertriglyceridaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-11
End date: 2012-03-02
Methotrexate
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-11
Hydrocortisone
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-11
Cytarabine
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Pegaspargase
Dosage: 2500 iu, unk
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-11
End date: 2012-03-02
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-11
End date: 2012-02-18
Doxorubicin HCL
Dosage: 60 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-11
End date: 2012-02-11
Prednisone TAB
Dosage: 20 mg/m2, cyclic
Administration route: Oral
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-11
End date: 2012-02-18
Possible Hydrocortisone side effects in 18 year old male
Reported by a physician from United States on 2012-02-21
Patient: 18 year old male, weighing 72.0 kg (158.4 pounds)
Reactions: Respiratory Failure, Platelet Count Decreased, Herpes Zoster, Klebsiella Sepsis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Methotrexate
Dosage: ;x1; inth ;x1; inth
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-12-29
End date: 2011-12-29
Methotrexate
Dosage: ;x1; inth ;x1; inth
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-13
End date: 2012-01-13
Prednisone TAB
Dosage: 20 ug/ m**2; bid; po
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-12-29
Vincristine
Dosage: 1.5 mg/ m**2; qw; iv
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-12-29
End date: 2012-01-28
Velcade
Dosage: 1.3 mg/m**2; qd; iv
Indication: Acute Leukaemia
Start date: 2011-12-29
End date: 2011-12-30
Cytarabine
Dosage: ;x1; inth
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-12-29
End date: 2011-12-29
Oncaspar
Dosage: 2500 iu/m2; qw; im
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-12-29
End date: 2012-01-28
Doxorubicin HCL
Dosage: 60 mg/ m**2; qd; iv
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-12-29
End date: 2011-12-30
Hydrocortisone
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-12-29
Possible Hydrocortisone side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from Australia on 2011-12-14
Patient: 56 year old female, weighing 82.5 kg (181.5 pounds)
Reactions: Blood Pressure Increased, Asthenopia, Chest Discomfort, Drug Hypersensitivity, Electrocardiogram T Wave Abnormal, Headache, Paraesthesia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Hydrocortisone
Dosage: 100 mg milligram(s)
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-12
End date: 2011-10-12
Oxaliplatin
Dosage: 220 mg milligram(s), intravenous drip
Indication: Chemotherapy
Start date: 2011-10-12
End date: 2011-10-12
Granisetron
Dosage: 2 mg milligram(s), oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-21
Granisetron
Dosage: 2 mg milligram(s), oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-12
End date: 2011-10-12
Oxaliplatin
Dosage: intravenous drip
Indication: Chemotherapy
Start date: 2011-09-21
Oxaliplatin
Dosage: 220 mg milligram(s), intravenous drip
Indication: Chemotherapy
Start date: 2011-10-12
End date: 2011-10-12
Loratadine
Dosage: 10 mg milligram(s)
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-12
End date: 2011-10-12
Dexamethasone
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-12
End date: 2011-10-12
Other drugs received by patient: Acetaminophen; Rosuvastatin; Loperamide HCL; Capecitabine; Metoclopramide
Possible Hydrocortisone side effects in 57 year old female
Reported by a health professional (non-physician/pharmacist) from Australia on 2011-11-23
Patient: 57 year old female, weighing 82.5 kg (181.5 pounds)
Reactions: Blood Pressure Increased, Dyspnoea, Chest Discomfort, Wheezing, Electrocardiogram T Wave Abnormal, Infusion Related Reaction
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Dexamethasone
Start date: 2011-10-12
End date: 2011-10-12
Oxaliplatin
Dosage: 220 mg;qd
Start date: 2011-10-12
End date: 2011-10-12
Loratadine
Dosage: 10 mg
Start date: 2011-10-12
End date: 2011-10-12
Hydrocortisone
Dosage: 100 mg
Start date: 2011-10-12
End date: 2011-10-12
Granisetron
Dosage: 2 mg
Start date: 2011-10-12
End date: 2011-10-12
Other drugs received by patient: Capecitabine
Possible Hydrocortisone side effects in female
Reported by a consumer/non-health professional from Australia on 2011-11-21
Patient: female, weighing 82.5 kg (181.5 pounds)
Reactions: Blood Pressure Increased, Dyspnoea, Chest Discomfort, Electrocardiogram Abnormal, Wheezing
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Dexamethasone
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-12
End date: 2011-10-12
Loratadine
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-12
End date: 2011-10-12
Hydrocortisone
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-12
End date: 2011-10-12
Granisetron
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-12
End date: 2011-10-12
Oxaliplatin
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-12
End date: 2011-10-12
Other drugs received by patient: Capecitabine
Possible Hydrocortisone side effects in 61 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2011-11-18
Patient: 61 year old female, weighing 66.0 kg (145.2 pounds)
Reactions: Death, Renal Failure, Respiratory Failure, Electrolyte Imbalance, Neuroleptic Malignant Syndrome
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Furosemide
Dosage: 40 mg
Administration route: Oral
Piperacillin and Tazobactam
Norepinephrine Bitartrate
Indication: Blood Pressure Management
Fluconazole
Administration route: Oral
Desipramide HCL
Dosage: 50 mg
Administration route: Oral
Haloperidol
Dosage: 20 mg
Administration route: Oral
Vasopressin
Indication: Blood Pressure Management
Fentanyl-100
Indication: Pain
Loperamide HCL
Administration route: Oral
Hydrocortisone
Cyproheptadine HCL
Indication: Serotonin Syndrome
Quetiapine
Dosage: 400 mg
Administration route: Oral
Trazodone HCL
Dosage: 200 mg
Administration route: Oral
Venlafaxine
Dosage: 150 mg
Administration route: Oral
Lorazepam
Dosage: 2 mg
Administration route: Oral
Risperidone
Dosage: 5 mg
Administration route: Oral
Prednisone TAB
Dosage: 7.5 mg
Administration route: Oral
Midazolam
Indication: Anxiety
Budesonide
Dantrolene Sodium
Indication: Neuroleptic Malignant Syndrome
Mometasone Furoate
Other drugs received by patient: Alendronate Sodium; Levothyroxine Sodium; Sumatriptan; Conjugated Estrogen; Albuterol Sulfate Autohaler; Atorvastatin; Cyclobenzaprine; Celecoxib; Omeprazole; Trimethoprim + Sulfamethoxazole; Hydroxychloroquinine; Hydroxyzine
Possible Hydrocortisone side effects in female
Reported by a physician from United States on 2011-11-09
Patient: female, weighing 81.6 kg (179.5 pounds)
Reactions: Pneumonia Fungal, Pneumonia, Osteomyelitis, Pneumocystis Jiroveci Pneumonia, Zygomycosis, Pneumonia Klebsiella, Respiratory Failure, Diarrhoea, Cytomegalovirus Infection, Ileitis, Fusarium Infection
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Remicade
Dosage: 1000 mg
Start date: 2011-09-02
Hydrocortisone
Indication: Crohn's Disease
Start date: 2011-09-06
End date: 2011-09-20
Remicade
Dosage: 400 mg
Indication: Crohn's Disease
Start date: 2011-08-15
Hydrocortisone
Start date: 2011-08-02
Entocort EC
Administration route: Oral
Indication: Crohn's Disease
Start date: 2011-07-01
End date: 2011-09-06
Remicade
Dosage: 400 mg
Start date: 2011-07-25
Possible Hydrocortisone side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-04
Patient: 50 year old female
Reactions: Anoxia, Hypersensitivity, Hyperhidrosis, Renal Ischaemia, Palpitations, Pulmonary Oedema, Myocarditis, Adrenal Mass, Respiratory Rate Increased, Chest Discomfort, Pneumonia, Metabolic Acidosis, Respiratory Distress, Glycogen Storage Disorder, Respiratory Acidosis, Renal Tubular Necrosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Hydrocortisone
Other drugs received by patient: Metoprolol Succinate; Amlodipine
Possible Hydrocortisone side effects in female
Reported by a physician from United States on 2011-11-02
Patient: female, weighing 81.6 kg (179.5 pounds)
Reactions: Pneumonia Fungal, Pneumonia, Osteomyelitis, Pneumocystis Jiroveci Pneumonia, Zygomycosis, Pneumonia Klebsiella, Diarrhoea, Cytomegalovirus Infection, Fusarium Infection
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Remicade
Dosage: 400 mg
Indication: Crohn's Disease
Start date: 2011-08-15
Hydrocortisone
Start date: 2011-08-02
Remicade
Dosage: 400 mg
Start date: 2011-07-25
Hydrocortisone
Indication: Crohn's Disease
Start date: 2011-09-06
End date: 2011-09-20
Entocort EC
Administration route: Oral
Indication: Crohn's Disease
Start date: 2011-07-01
End date: 2011-09-06
Remicade
Dosage: 1000 mg
Start date: 2011-09-02
|